These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 3793326)
1. Clofazimine-mediated regulation of human polymorphonuclear leukocyte migration by pro-oxidative inactivation of both leukoattractants and cellular migratory responsiveness. Anderson R; Lukey P; Van Rensburg C; Dippenaar U Int J Immunopharmacol; 1986; 8(6):605-20. PubMed ID: 3793326 [TBL] [Abstract][Full Text] [Related]
2. Enhancement by clofazimine and inhibition by dapsone of production of prostaglandin E2 by human polymorphonuclear leukocytes in vitro. Anderson R Antimicrob Agents Chemother; 1985 Feb; 27(2):257-62. PubMed ID: 3857019 [TBL] [Abstract][Full Text] [Related]
3. Benoxaprofen: a pro-oxidant anti-inflammatory drug? Anderson R; Lukey PT; Naudé SP; Jooné G Agents Actions; 1984 Feb; 14(2):238-46. PubMed ID: 6324560 [TBL] [Abstract][Full Text] [Related]
4. Effects of benoxaprofen on the binding to and inactivation of leucoattractants by human polymorphonuclear leucocytes in vitro. Anderson R; Lukey PT; van Rensburg CE Agents Actions; 1985 Sep; 16(6):527-34. PubMed ID: 4072830 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of polymorphonuclear leucocyte motility by benoxaprofen related to activation of cellular oxidative metabolism. Anderson R; Jooné G Int J Immunopharmacol; 1984; 6(4):269-74. PubMed ID: 6480193 [TBL] [Abstract][Full Text] [Related]
6. Lipopolysaccharide modulates receptors for leukotriene B4, C5a, and formyl-methionyl-leucyl-phenylalanine on rabbit polymorphonuclear leukocytes. Goldman DW; Enkel H; Gifford LA; Chenoweth DE; Rosenbaum JT J Immunol; 1986 Sep; 137(6):1971-6. PubMed ID: 3018083 [TBL] [Abstract][Full Text] [Related]
7. Dithranol mediates pro-oxidative inhibition of polymorphonuclear leukocyte migration and lymphocyte proliferation. Anderson R; Lukey PT; Dippenaar U; Eftychis HA; Findlay GH; Wooten MW; Nel AE Br J Dermatol; 1987 Oct; 117(4):405-18. PubMed ID: 3676090 [TBL] [Abstract][Full Text] [Related]
8. Clofazimine-mediated enhancement of reactive oxidant production by human phagocytes as a possible therapeutic mechanism. Anderson R; Zeis BM; Anderson IF Dermatologica; 1988; 176(5):234-42. PubMed ID: 2838344 [TBL] [Abstract][Full Text] [Related]
9. Regulation by the antioxidants ascorbate, cysteine, and dapsone of the increased extracellular and intracellular generation of reactive oxidants by activated phagocytes from cigarette smokers. Anderson R; Theron AJ; Ras GJ Am Rev Respir Dis; 1987 May; 135(5):1027-32. PubMed ID: 3034109 [TBL] [Abstract][Full Text] [Related]
10. Effects of clofazimine analogues and tumor necrosis factor-alpha individually and in combination on human polymorphonuclear leukocyte functions in vitro. Krajewska MM; Anderson R; O'Sullivan JF Int J Immunopharmacol; 1993 Feb; 15(2):99-111. PubMed ID: 8385654 [TBL] [Abstract][Full Text] [Related]
11. Protective effect of indomethacin against chemotactic deactivation of human neutrophils induced by formylated peptide. Perianin A; Gaudry M; Marquetty C; Giroud JP; Hakim J Biochem Pharmacol; 1988 May; 37(9):1693-8. PubMed ID: 2837237 [TBL] [Abstract][Full Text] [Related]
12. A derivative of wheat germ agglutinin specifically inhibits formyl-peptide-induced polymorphonuclear leukocyte chemotaxis by blocking re-expression (or recycling) of receptors. Perez HD; Elfman F; Lobo E; Sklar L; Chenoweth D; Hooper C J Immunol; 1986 Mar; 136(5):1803-12. PubMed ID: 3753993 [TBL] [Abstract][Full Text] [Related]
13. Oxidative inhibition of polymorphonuclear leukocyte motility mediated by the peroxidase/H2O2/halide system: studies on the reversible nature of the inhibition and mechanism of protection of migratory responsiveness by ascorbate, levamisole, thiamine and cysteine. Jones PT; Anderson R Int J Immunopharmacol; 1983; 5(5):377-89. PubMed ID: 6654535 [TBL] [Abstract][Full Text] [Related]
14. Human neutrophil Fc gamma RIIIB and formyl peptide receptors are functionally linked during formyl-methionyl-leucyl-phenylalanine-induced chemotaxis. Kew RR; Grimaldi CM; Furie MB; Fleit HB J Immunol; 1992 Aug; 149(3):989-97. PubMed ID: 1321856 [TBL] [Abstract][Full Text] [Related]
15. Granulocytes from chronic myeloid leukemia (CML) patients show differential response to different chemoattractants. Radhika V; Thennarasu S; Naik NR; Kumar A; Advani SH; Bhisey AN Am J Hematol; 1996 Jul; 52(3):155-64. PubMed ID: 8756080 [TBL] [Abstract][Full Text] [Related]
16. Ascorbate and cysteine-mediated selective neutralisation of extracellular oxidants during N-formyl peptide activation of human phagocytes. Anderson R; Lukey PT; Theron AJ; Dippenaar U Agents Actions; 1987 Feb; 20(1-2):77-86. PubMed ID: 3034003 [TBL] [Abstract][Full Text] [Related]
17. Effects of non-steroidal anti-inflammatory drugs on isolated human polymorphonuclear leukocytes (PMN): chemotaxis, superoxide production, degranulation and N-formyl-L-methionyl-L-leucyl-L-phenylalanine (FMLP) receptor binding. Shelly J; Hoff SF Gen Pharmacol; 1989; 20(3):329-34. PubMed ID: 2545509 [TBL] [Abstract][Full Text] [Related]
18. Heterogeneity in F-actin polymerization of cord blood polymorphonuclear leukocytes stimulated by N-formyl-methionyl-leucyl-phenylalanine. Taniuchi S; Kinoshita Y; Yamamoto A; Fujiwara T; Hattori K; Hasui M; Kobayashi Y Pediatr Int; 1999 Feb; 41(1):37-41. PubMed ID: 10200134 [TBL] [Abstract][Full Text] [Related]
19. Modulation of the heterogeneous membrane potential response of neutrophils to N-formyl-methionyl-leucyl-phenylalanine (FMLP) by leukotriene B4: evidence for cell recruitment. Fletcher MP J Immunol; 1986 Jun; 136(11):4213-9. PubMed ID: 3009618 [TBL] [Abstract][Full Text] [Related]
20. Priming induces functional coupling of N-formyl-methionyl-leucyl-phenylalanine receptors in equine neutrophils. Brazil TJ; Rossi AG; Haslett C; McGorum B; Dixon PM; Chilvers ER J Leukoc Biol; 1998 Mar; 63(3):380-8. PubMed ID: 9500527 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]